Percy Knolle

Title: Percy Knolle: Innovator in Vaccination Strategies

Introduction

Percy Knolle is a notable inventor based in Munich, Germany. He has made significant contributions to the field of vaccination strategies, particularly through his innovative approach to enhancing immune responses.

Latest Patents

Percy Knolle holds a patent for a vaccination strategy that utilizes TLR 9 and TLR 4 agonists. This invention focuses on using these agonists as multiplying jump agents to enhance the numbers and functionality of CD8 T cells in a prime-jump vaccination strategy. The strategy is particularly effective against acute and chronic infections with intracellular pathogens and for anti-tumor vaccination. Additionally, his patent includes a kit containing a prime agent and a multiplying jump agent.

Career Highlights

Throughout his career, Percy Knolle has worked with prestigious institutions such as Klinikum Rechts Der Isar der Technischen Universität München and Technische Universität München. His work has been instrumental in advancing the understanding and application of vaccination techniques.

Collaborations

Percy has collaborated with notable colleagues, including Li-Rung Huang and Mathias Heikenwälder. Their combined expertise has contributed to the development of innovative solutions in the field of immunology.

Conclusion

Percy Knolle's contributions to vaccination strategies highlight his role as an influential inventor in the medical field. His innovative approaches continue to pave the way for advancements in immunotherapy and vaccine development.